Dr. Maloney holds no commercial relationship with any reviewed clinic, marketplace, manufacturer, or industry body (no advisory roles, no equity, no consulting fees, no accepted travel or accommodation from any entity that is reviewed or could plausibly be reviewed). If that ever changes, the change is disclosed in the opening 100 words of every affected piece. Standing disclosures are at /disclosures/.
In twenty-three years of specialist endodontic practice, I have retreated hundreds of root canals that were performed overseas. I want to be precise about what I mean by “retreated”: I mean that a patient came to me with a tooth that had been root-canal-treated at an international clinic, was now symptomatic or showing a periapical lesion, and required the original treatment to be redone from scratch. Some of these cases were straightforward. Some were not. A few I could not save.
None of those patients came to me having been warned that the information they used to choose their clinic was systematically unreliable. They had read reviews, but didn’t know who wrote them or what financial relationship the reviewer had with the reviewed practice. They had checked certifications, but didn’t know that most dental certifications audit administrative procedures, not clinical-decision quality. They had compared prices, but didn’t know what the quoted price included and what it didn’t.
This publication exists because of those patients. Not to prevent them from travelling. Not to advocate for it. To give them better information than they currently have access to.
The gap
There is no shortage of content about dental tourism. There are marketplaces, aggregators, blogs, forum threads, YouTube channels, and social-media accounts covering dental tourism in more or less every destination country. Most of them are either (a) commercially entangled with the clinics they cover, (b) produced by patients reporting their own experience without clinical training to evaluate what they experienced, or (c) produced by writers who have no way to assess whether the clinical work performed was appropriate, well-executed, or durable.
None of these are the same as independent specialist clinical assessment.
The gap in dental tourism coverage is not a gap in volume. It is a gap in the qualification of the person doing the assessing. A positive patient review tells you something real and useful: this patient had a smooth experience, felt cared for, and had no immediate complications. It tells you nothing about whether the root canal morphology was adequately managed, whether the bone graft was clinically indicated, whether the implant placement angle will produce a maintainable emergence profile in five years. The patient cannot know those things. The patient’s reviewer, who is usually the same patient or a non-specialist writer, cannot know them either.
A marketplace review is something different again. Marketplace reviews are produced by platforms that earn revenue when patients book through them. The structural conflict of interest is not subtle. It is the business model. A platform that earns a booking fee from Clinic A cannot give Clinic A the same severity of scrutiny it would receive from a reviewer whose income is not connected to whether Clinic A books patients.
I am not accusing any specific marketplace of falsifying reviews. I am describing a structural incentive that would bias coverage in the positive direction even if every individual reviewer intended to be honest. The structural account of why marketplace incentives produce this result is documented separately. For the purposes of this piece, the point is simpler: the existing coverage ecosystem has a quality problem, and that quality problem falls hardest on the patients least able to absorb a clinical or financial complication.
Who this publication is for
This publication is for a specific kind of patient. Not every patient who is considering dental treatment overseas (there are millions of those, and most of their journeys go fine in a surface sense). This is for the patient who wants to make the decision properly.
That patient looks something like this: they have been quoted a significant sum domestically for a full-arch reconstruction, a molar root canal that needs a crown, or an implant case with a sinus lift recommendation. They have done their own research and found that the same work is available overseas for materially less money. They understand that there are risks. They want to know, specifically, what those risks are, whether the clinic they are considering is a competent clinic by clinical standards (not marketing standards), and how to evaluate the recommendation they have been given.
The publications that currently exist in this space will tell that patient where to go. This publication will tell that patient how to evaluate where they are thinking of going, and will sometimes tell them not to go at all, if the case complexity or the clinic’s documented gaps make that the honest answer.
The patient who disagrees with my assessment has every right to. What I am trying to eliminate is the situation where the patient doesn’t know enough to disagree.
What I am qualified to assess and what I am not
I am a specialist endodontist. I am qualified to assess endodontic treatment quality (root canal morphology management, obturation, preparation design, missed-canal detection, post-retreatment prognosis) at a level of specificity that a general dentist or a layperson cannot. I can look at a post-treatment radiograph and tell you things about it that are not visible to a non-specialist.
I am not a prosthodontist. I am not a periodontist. I am not an oral surgeon.
This means the implant reviews in this publication draw on my clinical experience reviewing referred cases, my reading of the peer-reviewed literature, and, for multi-specialty questions, consultation with specialist colleagues whose credentials are disclosed when their input is used. What I cannot credibly do is assess the emergence profile engineering of a full-arch zirconia case with the same authority I can assess the endodontic preparation of a molar root canal. I will say so directly when the assessment in a piece is outside my core specialty. I will name the evidence I am relying on.
This limitation is real. It is also better than the alternative: every existing dental tourism review is effectively produced by someone with either no clinical training or general dental training, covering cases that include full-arch reconstructions, complex bone graft sequences, and periodontal rehabilitation without the specialist depth to assess them. At least I know where my expertise ends.
What this publication does, specifically
Clinic reviews apply a published, five-category clinical-standards framework to named clinics. The framework is documented at the methodology page. Every category is scored against documented evidence, not impression. Every review names at least one specific gap: a deficiency I found, a protocol question I could not get answered, a radiographic pattern that concerned me. An all-positive clinic review is a structural red flag; a clinic that passes every category at every tier either hasn’t been looked at hard enough, or I have a relationship with it that I’m not disclosing. Neither is acceptable.
Treatment option reviews assess clinical decision frameworks: when to retreat vs. extract, when a sinus lift is genuinely indicated, when short implants are a defensible alternative to bone augmentation. These are the pieces where the financial incentive structure gets named directly: the practice-revenue difference between recommending extraction-and-implant vs. orthograde retreatment. The methodology for these pieces is documented at the treatment option reviews methodology page.
Reference content (cost tables, procedure explanations, risk frameworks) is the patient-education base. A patient who understands what a root canal actually involves, what reasonable cost ranges are by country and tier, and what questions to ask before consenting to a procedure, is a patient who is harder to mislead. The two-year-old cost figure or the procedure description that omits complications are the baseline failures of existing patient-education content; this publication uses dated figures, what’s-included specifications, and complications-included procedure descriptions.
Trial summaries apply the Cardiology Trials structural template to dental research: patients first, absolute numbers, external validity question, named funder. The dental literature has the same problems as the medical literature (industry-funded trials, surrogate endpoints, optimistic external validity claims), and the same critical-reading tools apply.
Weekly columns and Friday reflections carry the editorial thread through the week: news cycle reactive items in the Thursday column, patient-encounter narratives on Fridays. These are where the clinical witness is most direct and the analytical framework most compressed.
The commercial model, and why it matters
This publication is not free to operate. Site costs, travel for clinic visits, time: none of these are zero.
The commercial model I have committed to is straightforward: the publication earns from reader subscriptions and from the editorial reputation of the content. It does not earn from clinic referrals, booking commissions, sponsored clinic profiles, paid certification inclusion, or advertising from any entity in the dental tourism supply chain.
This is not a virtuous pose. It is a structural choice about what kind of publication this can be. A publication that earns from clinic referrals cannot give those clinics the same scrutiny as non-referring clinics. A publication that sells certification inclusion to clinics cannot score those clinics on an objective framework; or if it does, the score is untrustworthy to any reader who knows about the commercial relationship. The only publication that can credibly claim independence is the one that has structured its revenue away from every entity it covers.
I hold no commercial relationship with any reviewed clinic, marketplace, manufacturer, or industry body. I do not draw consulting fees from, hold equity in, sit on advisory boards of, or accept travel or accommodation from any entity that is reviewed or could plausibly be reviewed. The full disclosure registry is at /disclosures/. The default state of that registry is: no standing commercial relationships.
If that ever changes, I will disclose it in the opening 100 words of every piece that touches that entity. Not in a footer. Not in a disclosure tab. In paragraph one, where you can’t miss it.
What this publication is not
It is not a booking service. It does not refer patients to clinics.
It is not a certification body. Clinics cannot buy a badge or a listing here.
It does not give individual treatment advice. The editorial decision frameworks are inputs a patient can use to evaluate the recommendation they have received from a clinician. They are not a substitute for a domestic specialist second opinion, and they are not a substitute for the treating clinician’s assessment of the individual case. Every piece will tell you this, because it is true.
It is not a publication that will give you a clean answer when the evidence is messy. If the five-year survival data on a specific protocol is contested, I will tell you it’s contested, tell you who is on each side, and tell you what data would resolve the contest. “We don’t know” is a more useful piece of information than a confident answer that isn’t warranted.
The invitation
If you are a journalist, researcher, or regulator who wants to discuss the methodology, dispute an assessment, or offer data I haven’t seen: I want to hear from you. The corrections policy is real: if I’m wrong, I will say so, with a date and a description of what changed.
If you are a patient who has been through the international dental experience, good or bad or complicated, I would rather hear from you about the structural patterns you encountered than be approached by a clinic looking for a positive review. Patient-pattern letters inform the editorial calendar. Clinic approaches do not.
If you are a clinician who disagrees with a position taken in this publication — about retreatment success rates, about bone graft indications, about what the published evidence on All-on-4 actually shows — write to me with the evidence. The methodology is published. The argument can be public.
The Maloney Review is not the only source a sophisticated patient needs. It is one of several imperfect remedies that improve the odds when stacked. The treatment option frameworks, the cost references, the procedure references: these are the building blocks. The patient who uses them alongside a domestic specialist second opinion and a careful look at the destination clinic’s certification is better positioned than the patient who uses any one of them alone.
That’s the publication. My name and AHPRA registration are on everything published here. That’s the accountability structure. It’s the only one I know how to operate under.